AU2003294728A1 - DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) - Google Patents
DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)Info
- Publication number
- AU2003294728A1 AU2003294728A1 AU2003294728A AU2003294728A AU2003294728A1 AU 2003294728 A1 AU2003294728 A1 AU 2003294728A1 AU 2003294728 A AU2003294728 A AU 2003294728A AU 2003294728 A AU2003294728 A AU 2003294728A AU 2003294728 A1 AU2003294728 A1 AU 2003294728A1
- Authority
- AU
- Australia
- Prior art keywords
- pde9a2
- therapeutics
- diagnostics
- diseases associated
- human phosphodiesterase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02027532.7 | 2002-12-09 | ||
EP02027532 | 2002-12-09 | ||
PCT/EP2003/013280 WO2004053494A1 (en) | 2002-12-09 | 2003-11-26 | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003294728A1 true AU2003294728A1 (en) | 2004-06-30 |
Family
ID=32479718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003294728A Abandoned AU2003294728A1 (en) | 2002-12-09 | 2003-11-26 | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1573333A1 (en) |
AU (1) | AU2003294728A1 (en) |
WO (1) | WO2004053494A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2672591A1 (en) * | 2006-12-13 | 2008-06-19 | Aska Pharmaceutical Co., Ltd. | Treating agent of uropathy |
PE20110383A1 (en) * | 2008-09-08 | 2011-07-15 | Boehringer Ingelheim Int | PYRAZOLOPYRIMIDINONES AS INHIBITORS OF PHOSPHODIESTERASE 9A (PDE9A) |
KR101695866B1 (en) * | 2009-05-12 | 2017-01-13 | 코닌클리케 필립스 엔.브이. | Phosphodiesterase 9a as prostate cancer marker |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002504341A (en) * | 1998-02-23 | 2002-02-12 | アイコス コーポレイション | Phosphodiesterase 10 |
-
2003
- 2003-11-26 WO PCT/EP2003/013280 patent/WO2004053494A1/en not_active Application Discontinuation
- 2003-11-26 EP EP03785666A patent/EP1573333A1/en not_active Ceased
- 2003-11-26 AU AU2003294728A patent/AU2003294728A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1573333A1 (en) | 2005-09-14 |
WO2004053494A1 (en) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003251471A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) | |
AU2003276220A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) | |
AU2003301894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
AU2003229735A1 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
AU2003276136A1 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
AU2003294728A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) | |
AU2003283303A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) | |
AU2003205627A1 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
AU2003283427A1 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) | |
AU2003279361A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) | |
AU2003274083A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) | |
AU2003267380A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) | |
AU2003288171A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3) | |
AU2003288158A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) | |
AU2003289894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) | |
AU2003279323A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) | |
AU2003282087A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) | |
AU2003276187A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) | |
AU2003274082A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) | |
AU2003279322A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) | |
AU2003301913A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) | |
AU2003283302A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) | |
AU2003218638A1 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
AU2003250221A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6) | |
AU2003267443A1 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |